These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17526110)

  • 1. 14th annual retrovirus conference (CROI). Conference round-up. New lipo drug, rapid testing, and more news from CROI.
    Vázquez E
    Posit Aware; 2007; 18(3):24-5. PubMed ID: 17526110
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic trial of growth hormone releasing factor in HIV patients.
    Winslow DL
    AIDS Alert; 2008 Apr; 23(4):45-6. PubMed ID: 19253454
    [No Abstract]   [Full Text] [Related]  

  • 3. Tesamorelin update.
    O'Neal R
    BETA; 2010; 22(4):16-9. PubMed ID: 21591600
    [No Abstract]   [Full Text] [Related]  

  • 4. Tesamorelin for fat accumulation. 52-week effects and safety of tesamorelin (growth hormone releasing factor) in HIV patients with fat accumulation.
    Berger D
    Posit Aware; 2008; 19(3):31. PubMed ID: 18724445
    [No Abstract]   [Full Text] [Related]  

  • 5. Complications & side effects. Can TH9057 reduce fat deposits?
    TreatmentUpdate; 2004; 16(7):3. PubMed ID: 17219684
    [No Abstract]   [Full Text] [Related]  

  • 6. TH9507: an experimental treatment for lipodystrophy.
    Monroe A
    BETA; 2007; 19(4):16-9. PubMed ID: 18069152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side effects and complications. Clinical trials of tesamorelin in Canada.
    TreatmentUpdate; 2007; 19(3):7. PubMed ID: 17571443
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of growth hormone-releasing factor in HIV-infected patients.
    Malgarini RB; Pimpinella G
    N Engl J Med; 2008 Feb; 358(9):969; author reply 969-70. PubMed ID: 18305274
    [No Abstract]   [Full Text] [Related]  

  • 9. Manipulation of the growth hormone axis in patients with HIV infection.
    Blackman MR
    N Engl J Med; 2007 Dec; 357(23):2397-9. PubMed ID: 18057344
    [No Abstract]   [Full Text] [Related]  

  • 10. The next generation of human growth hormone. How Serostim and tesamorelin measure up.
    Grodeck B
    Posit Aware; 2008; 19(5):28-32. PubMed ID: 18828236
    [No Abstract]   [Full Text] [Related]  

  • 11. [Venereal diseases: tests influenced by HIV. Herpes genitalis--HPV-syphilis].
    Moosmann EB
    Fortschr Med; 1990 May; 108(14):26, 28. PubMed ID: 2165030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Definition of sexually transmissible diseases. Relationship between sexually transmitted diseases and HIV infection].
    Laga M; Crabbé F
    Acta Urol Belg; 1993; 61(1-2):55-60. PubMed ID: 8517273
    [No Abstract]   [Full Text] [Related]  

  • 13. New lipodystrophy drug.
    AIDS Patient Care STDS; 2007 Apr; 21(4):290. PubMed ID: 17506143
    [No Abstract]   [Full Text] [Related]  

  • 14. 14th annual retrovirus conference (CROI). New drugs at CROI: the four musketeers. New drugs new targets, new hope.
    Berry J
    Posit Aware; 2007; 18(3):21-3. PubMed ID: 17526109
    [No Abstract]   [Full Text] [Related]  

  • 15. 14th annual retrovirus conference (CROI). CROI vaccine update. Several HIV vaccine trials testing efficacy are underway.
    Fisher K
    Posit Aware; 2007; 18(3):28. PubMed ID: 17526112
    [No Abstract]   [Full Text] [Related]  

  • 16. Report from San Francisco: The 11th Conference on Retroviruses and Opportunistic Infections (CROI). Lipodystrophy and metabolic complications.
    Cofrancesco J
    Hopkins HIV Rep; 2004 Mar; 16(2):12-4. PubMed ID: 15119312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Testing for other infections in connection with the HIV test is recommended].
    Strand A; Hallén A; Linglöf T
    Lakartidningen; 1994 Apr; 91(17):1691-2. PubMed ID: 8189900
    [No Abstract]   [Full Text] [Related]  

  • 18. Selected abstracts from the 9th Annual Retrovirus Conference.
    Boyle BA
    AIDS Read; 2002 May; 12(5):182-7. PubMed ID: 12056112
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing the effectiveness of HIV counseling.
    Hirano D; Slaughter FR; Sands L; Gellert GA
    Am J Public Health; 1994 Jul; 84(7):1179-80. PubMed ID: 8017552
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV and pregnancy at the 12 CROI.
    Anderson JR
    Hopkins HIV Rep; 2005 Mar; 17(2):6-7, 9. PubMed ID: 16419317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.